PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Clinical trial NCT01445899 · COMPLETED

Trial details

NCT number: NCT01445899
Sponsor: Quark Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Choroidal Neovascularization Diabetic Retinopathy Diabetic Macular Edema

Start date: 2012-02-01
Primary completion: 2013-11-01
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.